These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 22594305)

  • 1. Esophageal motor dysfunction plays a key role in GERD with globus sensation--analysis of factors promoting resistance to PPI therapy.
    Tsutsui H; Manabe N; Uno M; Imamura H; Kamada T; Kusunoki H; Shiotani A; Hata J; Harada T; Haruma K
    Scand J Gastroenterol; 2012 Sep; 47(8-9):893-9. PubMed ID: 22594305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of proton pump inhibitor-resistant nonerosive reflux disease by esophageal manometry and 24-hour esophageal impedance and pH monitoring.
    Kawamura O; Hosaka H; Shimoyama Y; Kawada A; Kuribayashi S; Kusano M; Yamada M
    Digestion; 2015; 91(1):19-25. PubMed ID: 25632912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH Impedance and high-resolution manometry in laryngopharyngeal reflux disease high-dose proton pump inhibitor failures.
    Carroll TL; Fedore LW; Aldahlawi MM
    Laryngoscope; 2012 Nov; 122(11):2473-81. PubMed ID: 22965767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically distinct characteristics in patients younger than 40 years old with non-cardiac chest pain.
    Ko SY; Kim SI; Kim JH; Lee JH; Lee KJ; Hong SN; Lee SY; Sung IK; Park HS; Shim CS
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1484-9. PubMed ID: 22554344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?
    de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S
    World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transition zone defect associated with the response to proton pump inhibitor treatment in patients with globus sensation.
    Han MS; Lee H; Jo JH; Cho IR; Park JC; Shin SK; Lee SK; Lee YC
    J Gastroenterol Hepatol; 2013 Jun; 28(6):954-62. PubMed ID: 23425059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of esophageal motility abnormalities in severe reflux esophagitis].
    Xu JY; Xie XP; Hou XH
    Zhonghua Nei Ke Za Zhi; 2005 May; 44(5):353-5. PubMed ID: 16009005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of esophageal motility in gastroesophageal reflux disease with and without globus sensation.
    Tang Y; Huang J; Zhu Y; Qian A; Xu B; Yao W
    Rev Esp Enferm Dig; 2017 Dec; 109(12):850-855. PubMed ID: 29082739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of duodenogastroesophageal reflux in gastroesophageal reflux disease patients refractory to proton pump inhibitor therapy.
    Kunsch S; Neesse A; Linhart T; Nell C; Gress TM; Ellenrieder V
    Digestion; 2012; 86(4):315-22. PubMed ID: 23128301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of acid suppression success in patients with chronic laryngitis.
    Wang AJ; Liang MJ; Jiang AY; Lin JK; Xiao YL; Peng S; Chen J; Wen WP; Chen MH
    Neurogastroenterol Motil; 2012 May; 24(5):432-7, e210. PubMed ID: 22276941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults.
    Molina-Infante J; Ferrando-Lamana L; Ripoll C; Hernandez-Alonso M; Mateos JM; Fernandez-Bermejo M; Dueñas C; Fernandez-Gonzalez N; Quintana EM; Gonzalez-Nuñez MA
    Clin Gastroenterol Hepatol; 2011 Feb; 9(2):110-7. PubMed ID: 20920599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of distal esophageal impedance in individuals with and without esophageal motility abnormalities.
    Blonski W; Hila A; Vela MF; Castell DO
    J Clin Gastroenterol; 2008 Aug; 42(7):776-81. PubMed ID: 18360293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esophageal acid exposure decreases intraluminal baseline impedance levels.
    Kessing BF; Bredenoord AJ; Weijenborg PW; Hemmink GJ; Loots CM; Smout AJ
    Am J Gastroenterol; 2011 Dec; 106(12):2093-7. PubMed ID: 21844921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of proton pump inhibitors in patients with laryngopharyngeal reflux disease.
    Chiba T; Kudara N; Abiko Y; Endo M; Suzuki K; Sugai T; Ishijima K; Fukuda K; Yamazaki K; Sato H
    Hepatogastroenterology; 2011; 58(110-111):1580-2. PubMed ID: 21940324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study with pharyngeal and esophageal 24-hour pH-impedance monitoring in patients with laryngopharyngeal symptoms refractory to proton pump inhibitors.
    Dulery C; Lechot A; Roman S; Bastier PL; Stoll D; de Gabory L; Zerbib F
    Neurogastroenterol Motil; 2017 Jan; 29(1):. PubMed ID: 27424517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology and treatment of patients with globus sensation--from the viewpoint of esophageal motility dysfunction.
    Manabe N; Tsutsui H; Kusunoki H; Hata J; Haruma K
    J Smooth Muscle Res; 2014; 50():66-77. PubMed ID: 26081369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic surgery for gastroesophageal reflux disease patients with impaired esophageal peristalsis: total or partial fundoplication?
    Chrysos E; Tsiaoussis J; Zoras OJ; Athanasakis E; Mantides A; Katsamouris A; Xynos E
    J Am Coll Surg; 2003 Jul; 197(1):8-15. PubMed ID: 12831918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased proximal reflux in a hypersensitive esophagus might explain symptoms resistant to proton pump inhibitors in patients with gastroesophageal reflux disease.
    Rohof WO; Bennink RJ; de Jonge H; Boeckxstaens GE
    Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1647-55. PubMed ID: 24184737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased esophageal mucosal/submucosal blood flow in patients with gastroesophageal reflux disease: normalization by treatment with a proton pump inhibitor.
    Mine S; Iida T; Tabata T; Okada Y; Tanaka Y
    J Gastroenterol Hepatol; 2008 Feb; 23(2):303-9. PubMed ID: 17725600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.